Peptirna Therapeutics Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Peptirna Therapeutics Co., Ltd. - overview
Established
2023
Location
Seongnam, -, South Korea
Primary Industry
Pharmaceuticals
About
Based on Seongnam, South Korea, and founded in 2023, Peptirna Therapeutics Co. , Ltd. operates as a company that develops a drug delivery system using small-interfering ribonucleic acid to block disease-causing proteins preventing disease from its source. In December 2025, PEPTIRNA THERAPEUTICS raised seed funding from WOW Partners.
Peptirna Therapeutics is a biotech startup specializing in siRNA (small‑interfering RNA) drug delivery technologies, particularly addressing one of the biggest challenges in RNA therapeutics: effective delivery beyond liver cells. The company has developed Pepticellplex, a proprietary peptide‑based delivery platform that binds with siRNA molecules to transport them into extra‑hepatic target cells while also enabling endosomal escape, ensuring siRNA remains functional inside cells.
Current Investors
WOW Partners
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Healthcare IT, Pharmaceutical Research & Development
Verticals
HealthTech, Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Peptirna Therapeutics Co., Ltd. - financials
| Fiscal Year Ended | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|
| Revenue (USD) | - | - |
| % Revenue Growth (YoY) | - | - |
| EBITDA (USD) | - | - |
| Operating Income (USD) | - | - |
| Operating Margin | - | - |
| % EBITDA Margin | - | - |
| NET Income (USD) | - | - |
| % Net Margin | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.